143 related articles for article (PubMed ID: 30763230)
1. Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?
Goldberg H; Cheung DC; Chandrasekar T; Klaassen Z; Wallis CJD; Kulkarni GS; Sayyid R; Evans A; Masoomian M; Bapat B; van der Kwast T; Hamilton RJ; Zlotta A; Fleshner N
Can Urol Assoc J; 2019 Sep; 13(9):E292-E299. PubMed ID: 30763230
[TBL] [Abstract][Full Text] [Related]
2. Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database Study.
Inamoto T; Matsuyama H; Komura K; Ibuki N; Fujimoto K; Shiina H; Sakano S; Nagao K; Mastumoto H; Miyake M; Tatsumi Y; Yasumoto H; Azuma H
Curr Urol; 2020 Dec; 14(4):183-190. PubMed ID: 33488336
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
4. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis.
Moschini M; Zamboni S; Afferi L; Pradere B; Abufaraj M; Soria F; D'Andrea D; Roupret M; De la Taille A; Simeone C; Mattei A; Mathieu R; Bensalah K; Wirth MP; Montorsi F; Briganti A; Gallina A; Simone G; Gallucci M; Di Bona C; Marra G; Mari A; Di Trapani E; Alvarez Maestro M; Krajewski W; Shariat SF; Xylinas E; Baumeister P
Arab J Urol; 2020 Sep; 19(1):31-36. PubMed ID: 33763246
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience.
Elawdy MM; Osman Y; Taha DE; Zahran MH; El-Halwagy S; Garba ME; Harraz AM
Arab J Urol; 2017 Sep; 15(3):216-222. PubMed ID: 29071155
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study.
Nuhn P; Novara G; Seitz C; Gupta A; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Tritschler S; Martínez-Salamanca JI; Ficarra V; Karakiewicz PI; Mazzoleni G; Shariat SF; Bastian PJ
World J Urol; 2015 Jul; 33(7):1005-13. PubMed ID: 25048439
[TBL] [Abstract][Full Text] [Related]
10. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
[TBL] [Abstract][Full Text] [Related]
11. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.
Lee DJ; Xylinas E; Rieken M; Khani F; Klatte T; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Guo CC; Rioux-Leclercq N; Haitel A; Bolenz C; Bensalah K; Sagalowsky AI; Montorsi F; Lotan Y; Shariat SF; Robinson BD; Margulis V
Eur Urol; 2014 Aug; 66(2):379-85. PubMed ID: 24388440
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
Seisen T; Mari A; Campi R; Peyronnet B; Bensalah K; Rioux-Leclercq N; Pfister C; Gobet F; De La Taille A; Allory Y; Xylinas E; Neuzillet Y; Radulescu C; Descotes JL; Saada-Sebag G; Irani J; Delpech-Debiais C; Bigot P; Eymerit C; Crouzet S; Mege-Lechevallier F; Ruffion A; Decaussin-Petrucci M; Droupy S; Roger P; Durand X; Camparo P; Cussenot O; Compérat E; Rouprêt M
Eur Urol Focus; 2021 Sep; 7(5):1075-1083. PubMed ID: 33463527
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy: A cohort study.
Milojevic B; Dzamic Z; Grozdic Milojevic I; Bumbasirevic U; Santric V; Kajmakovic B; Janicic A; Durutovic O; Dragicevic D; Bojanic N; Radisavcevic D; Sipetic Grujicic S
Urol Oncol; 2021 Nov; 39(11):786.e9-786.e16. PubMed ID: 34006438
[TBL] [Abstract][Full Text] [Related]
18. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
[TBL] [Abstract][Full Text] [Related]
20. Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.
Freifeld Y; Ghandour R; Singla N; Woldu S; Clinton T; Kulangara R; Bagrodia A; Matin SF; Petros FG; Raman JD; Robyak H; Yan J; Zhu H; Rapoport L; Lotan Y; Margulis V
Urol Oncol; 2019 Oct; 37(10):758-764. PubMed ID: 31378586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
